Trial · NCT00304070
Results by group111
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 111
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Five Year Event-free Survival (EFS) | Stratum 1 | 0.86 | 95% Confidence Interval 0.62 to 0.95 | Estimated probability five year EFS | |
| Five Year Event-free Survival (EFS) | Stratum 2 | 0.53 | 95% Confidence Interval 0.26 to 0.74 | Estimated probability five year EFS | |
| Five Year Event-free Survival (EFS) | Stratum 3 | 0.51 | 95% Confidence Interval 0.33 to 0.66 | Estimated probability five year EFS | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Abdominal Infection | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Abdominal Pain | 2 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Acidosis | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Activated Partial Thromboplastin Time Prolonged | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Adrenal Insufficiency | 5 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Alanine Aminotransferase Increased | 2 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Allergic Reaction | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Anemia | 22 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Anorexia | 7 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Aspartate Aminotransferase Increased | 2 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Blood Bilirubin Increased | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Cardiac Disorders - Other, Specify | 2 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Catheter Related Infection | 3 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Colitis | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Confusion | 1 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Dehydration | 3 | participants | |
| Toxicity Associated With Chemotherapy Using National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 | Stratum 3 | Incidence of Depressed Level of Consciousness | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00304070/results